创伤性脑损伤评估市场、机会、成长动力、产业趋势分析与预测，2024-2032

Traumatic Brain Injuries Assessment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月07日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球创伤性脑损伤(TBI) 评估市场估值为29 亿美元，预计2024 年至2032 年复合年增长率为7.4%。上升、人口老化、与运动相关的头部损伤增加，以及医疗保健支出增加。

TBI 由事故、跌倒、运动伤害或暴力引起，是全世界发病和死亡的主要原因。有效的评估工具对于及时诊断和管理 TBI 至关重要。神经影像（MRI、CT 扫描）、生物标记识别和可携式诊断设备的最新技术进步显着提高了 TBI 评估的速度、准确性和便利性。这些创新增强了医疗保健专业人员更有效地诊断和管理 TBI 的能力，从而改善患者的治疗效果并促进市场成长。

TBI评估涉及评估外力引起的脑损伤，通常透过临床评估、神经影像学和生物标记分析来评估损伤严重程度并指导治疗。

市场主要分为两大类产品：筛选设备和监控设备。包括 CT 和 MRI 扫描在内的筛检设备在 2023 年创造了 23 亿美元的收入，处于市场领先地位。监测设备重点在于颅内压 (ICP) 和脑组织中的氧分压 (pBrO2)。

人们对运动相关脑震盪及其长期影响的认识不断提高，推动了筛检设备的采用，特别是在体育组织、教育机构和专业团队中。技术进步也促进了便携式神经影像工具和手持设备的发展，增强了 TBI 的检测和评估，进一步推动了筛选设备市场的发展。

医院作为 TBI 病例的主要护理点，在 2023 年成为主要的最终使用领域，预计到 2032 年市场价值将达到 32 亿美元。并改善患者治疗效果。

2023年，北美以12亿美元的收入引领TBI评估市场。该地区强大的医疗基础设施、先进的医疗技术以及神经影像和便携式诊断工具的持续创新奠定了其主导地位。北美对先进诊断方法和医疗设备创新的关注确保了持续成长，预计到 2032 年复合年增长率为 6.8%。

产业生态系统分析
产业影响力
- 成长动力
  - 创伤性脑损伤的发生率不断上升
  - 创伤性脑损伤评估的技术进步
  - 对用于 TBI 评估的非侵入性设备的需求不断增加
  - 对创伤性脑损伤的认识不断提高
- 产业陷阱与挑战
  - 缺乏熟练的专业人员
  - 评估设备成本高
成长潜力分析
监管环境
技术景观
2023 年定价分析
价值链分析
差距分析
主要市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
筛选装置
- 电脑断层扫描 (CT) 扫描
- 磁振造影 (MRI)
- 其他筛选设备
监控设备
- 颅内压 (ICP) 监测
- 脑组织中的氧分压 (pBrO2)

第 6 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
医院
诊断中心
其他最终用户

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Accuray Incorporated
Asahi Kasei Corporation
BrainScope, Inc.
Compumedics Ltd.
CurveBeam AI, Ltd.
FUJIFILM Holdings Corporation
GE Healthcare
InfraScan, Inc.
Koninklijke Philips NV
Natus Medical, Inc.
Neusoft Corporation
Nihon Kohden Corporation
Oculogica
Raumedic AG
Siemens Healthineers AG

简介目录

Product Code: 5931

The Global Traumatic Brain Injury (TBI) Assessment Market was valued at USD 2.9 billion in 2023, with a projected CAGR of 7.4% from 2024 to 2032. Key factors driving this growth include advancements in diagnostic technologies, rising TBI incidences, an aging population, an increase in sports-related head injuries, and expanding healthcare expenditures.

TBIs, which result from accidents, falls, sports injuries, or violence, are a leading cause of morbidity and mortality worldwide. Effective assessment tools are crucial for the timely diagnosis and management of TBIs. Recent technological advancements in neuroimaging (MRI, CT scans), biomarker identification, and portable diagnostic devices have significantly improved the speed, accuracy, and convenience of TBI assessments. These innovations enhance healthcare professionals' ability to diagnose and manage TBIs more efficiently, leading to improved patient outcomes and contributing to market growth.

TBI assessment involves evaluating brain injuries caused by external forces, typically through clinical evaluations, neuroimaging, and biomarker analysis, to assess injury severity and guide treatment.

The market is divided into two main product categories: screening devices and monitoring devices. Screening devices, which include CT and MRI scans, generated USD 2.3 billion in 2023, leading the market. Monitoring devices focus on intracranial pressure (ICP) and the partial pressure of oxygen in brain tissue (pBrO2).

The increasing awareness of sports-related concussions and their long-term effects has driven the adoption of screening devices, particularly within sports organizations, educational institutions, and professional teams. Technological advancements have also led to the development of portable neuroimaging tools and handheld devices, which enhance the detection and assessment of TBIs, further driving the market for screening devices.

Hospitals, as the primary point of care for TBI cases, emerged as the dominant end use segment in 2023, with projections suggesting a market value of USD 3.2 billion by 2032. Hospitals rely heavily on advanced diagnostic tools to deliver swift and accurate TBI diagnoses, supporting specialized care and improving patient outcomes.

In 2023, North America led the TBI assessment market with USD 1.2 billion in revenue. The region's robust healthcare infrastructure, advanced medical technologies, and continuous innovations in neuroimaging and portable diagnostic tools contribute to its dominant position. North America's focus on advanced diagnostic methods and medical device innovations ensures continued growth, with a projected CAGR of 6.8% through 2032.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing incidence of traumatic brain injuries
  - 3.2.1.2 Technological advancements in traumatic brain injuries assessment
  - 3.2.1.3 Increasing demand for non-invasive devices for TBI assessment
  - 3.2.1.4 Rising awareness regarding traumatic brain injury
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Dearth of skilled professionals
  - 3.2.2.2 High cost of assessment devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pricing analysis, 2023
3.7 Value chain analysis
3.8 Gap analysis
3.9 Key market trends
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Screening devices
- 5.2.1 Computerized tomography (CT) scan
- 5.2.2 Magnetic resonance imaging (MRI)
- 5.2.3 Other screening devices
5.3 Monitoring devices
- 5.3.1 Intracranial pressure (ICP) monitoring
- 5.3.2 Partial pressure of oxygen in brain tissue (pBrO2)

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Diagnostic centers
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa